Attila Karakus

1.2k total citations
4 papers, 340 citations indexed

About

Attila Karakus is a scholar working on Epidemiology, Emergency Medicine and Pharmacology. According to data from OpenAlex, Attila Karakus has authored 4 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Epidemiology, 2 papers in Emergency Medicine and 1 paper in Pharmacology. Recurrent topics in Attila Karakus's work include Emergency and Acute Care Studies (2 papers), Antibiotics Pharmacokinetics and Efficacy (1 paper) and Antibiotic Resistance in Bacteria (1 paper). Attila Karakus is often cited by papers focused on Emergency and Acute Care Studies (2 papers), Antibiotics Pharmacokinetics and Efficacy (1 paper) and Antibiotic Resistance in Bacteria (1 paper). Attila Karakus collaborates with scholars based in Netherlands. Attila Karakus's co-authors include Kit CB Roes, Michaël Kuiper, Peter E. Spronk, Willem A. van Gool, Arjen J. C. Slooter, Marina L. H. Honing, Jozef Kesecioğlu, Mathieu van der Jagt, Roos C. van der Mast and Lenneke Haas and has published in prestigious journals such as The Lancet, Intensive Care Medicine and Critical Care.

In The Last Decade

Attila Karakus

4 papers receiving 335 citations

Peers

Countries citing papers authored by Attila Karakus

Since Specialization

Citations

This map shows the geographic impact of Attila Karakus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Attila Karakus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Attila Karakus more than expected).

Fields of papers citing papers by Attila Karakus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Attila Karakus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Attila Karakus. The network helps show where Attila Karakus may publish in the future.

Co-authorship network of co-authors of Attila Karakus

This figure shows the co-authorship network connecting the top 25 collaborators of Attila Karakus. A scholar is included among the top collaborators of Attila Karakus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Attila Karakus. Attila Karakus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

#	Work	Indexed citations
1	Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial 2022 ·Intensive Care Medicine ·Tim M. J. Ewoldt, Alan Abdulla, Wim J. R. Rietdijk, Anouk E. Muller, Brenda C. M. de Winter, Nicole Hunfeld, Ilse M. Purmer, Peter Van de Vliet, Evert‐Jan Wils, Jasper J. Haringman, Annelies Draisma, Tom A. Rijpstra, Attila Karakus, Diederik Gommers, Henrik Endeman, Birgit C. P. Koch	60
2	Trends in short-term and 1-year mortality in very elderly intensive care patients in the Netherlands: a retrospective study from 2008 to 2014 2017 ·Intensive Care Medicine ·Attila Karakus, Lenneke Haas, Sylvia Brinkman, Dylan W. de Lange, Nicolette F. de Keizer	21
3	Trends in hospital and intensive care admissions in the Netherlands attributable to the very elderly in an ageing population 2015 ·Critical Care ·Lenneke Haas, Attila Karakus, Rebecca Holman, Sezgin Cihangir, Auke C. Reidinga, Nicolette F. de Keizer	43
4	Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial 2010 ·The Lancet ·(unknown), Kit CB Roes, Marina L. H. Honing, Michaël Kuiper, Attila Karakus, Mathieu van der Jagt, Peter E. Spronk, Willem A. van Gool, Roos C. van der Mast, Jozef Kesecioğlu, Arjen J. C. Slooter	216

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact